BTK and Bruton-type agammaglobulinemia: In 1993, two groups identified that the BTK protein is mutated in patients with XLA, leading to compromised B-cell development in the bone marrow with subsequent depletion of serum immunoglobulins and humoral immunodeficiency [9,10].